OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance
Baimei Zhuang, Jin Shang, Yuanqing Yao
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62

Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9

HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66

First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors
Lillian L. Siu, Ding Wang, John Hilton, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 1, pp. 57-70
Open Access | Times Cited: 52

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45

Human leukocyte immunoglobulin-like receptors in health and disease
Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16

The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Jiji V. D. Attia, Charlotte E. Dessens, Ricky B. van de Water, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8678-8678
Open Access | Times Cited: 40

Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Mi Deng, Heyu Chen, Xiaoye Liu, et al.
Antibody Therapeutics (2021) Vol. 4, Iss. 1, pp. 16-33
Open Access | Times Cited: 34

LILRB2 inhibition enhances radiation sensitivity in non-small cell lung cancer by attenuating radiation-induced senescence
Xiaozheng Chen, Meng Yuan, Zhong Tao, et al.
Cancer Letters (2024) Vol. 593, pp. 216930-216930
Open Access | Times Cited: 5

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
Qiong-Yuan Chen, Yuxin Chen, Qiu-Yue Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 30

Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy
Calvin D. De Louche, Ali Roghanian
JCI Insight (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 21

Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis
Qin Yang, Kaihu Li, Xin Li, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 14, pp. 2063-2076
Open Access | Times Cited: 29

Emerging roles of miR-145 in gastrointestinal cancers: A new paradigm
Mohammad Roshani, Danial Molavizadeh, Sara Sadeghi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115264-115264
Open Access | Times Cited: 9

ILT4 facilitates angiogenesis in non‐small cell lung cancer
Shuyun Wang, Jing Wang, Wenjing Gong, et al.
Cancer Science (2024) Vol. 115, Iss. 5, pp. 1459-1475
Open Access | Times Cited: 3

Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients
Vladimı́ra Ďurmanová, Miroslav Tedla, Dusan Rada, et al.
Diseases (2024) Vol. 12, Iss. 2, pp. 34-34
Open Access | Times Cited: 2

LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation
Zhiyuan Jiang, Qianru Huang, Yujie Chang, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1679-1696
Closed Access | Times Cited: 2

A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
Ricky B. van de Water, Daniëlle Krijgsman, Ruben D. Houvast, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8265-8265
Open Access | Times Cited: 16

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
Peilong Li, Nan Wang, Yi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16

Comprehensive analysis of LILR family genes expression and tumour‐infiltrating immune cells in early‐stage pancreatic ductal adenocarcinoma
Qiang Gao, Shutian Mo, Chuangye Han, et al.
IET Systems Biology (2023) Vol. 17, Iss. 2, pp. 39-57
Open Access | Times Cited: 6

Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer.
Jing Liu, Fang Zhang, Jié He, et al.
PubMed (2023) Vol. 13, Iss. 2, pp. 419-435
Closed Access | Times Cited: 6

Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis
Yongjia Peng, Jian Xiao, Wenyun Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13

The Genomic Organization of the LILR Region Remained Largely Conserved Throughout Primate Evolution: Implications for Health And Disease
Lisanne Storm, Jesse Bruijnesteijn, Natasja G. de Groot, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 13

An HLA-G/SPAG9/STAT3 axis promotes brain metastases
Blessing Bassey‐Archibong, Chirayu Chokshi, Nikoo Aghaei, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 8
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top